The Latest Breaking News on Pharma

The Food and Drug Administration granted Amylyx Pharmaceuticals a hard-won approval in ALS treatment, but AMLX stock sank Friday.

According to a scientific study pub

Reuters

For the Drug Enforcement Administration (DEA), physicians who seek psilocybin for their dying patients under federal Right to Try (RTT) laws are making a request for a ‘commercial use.’ The DEA is implying that doctors who want to give terminally ill patients psilocybin have a financial interest, making them ineligible for a f

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of the vaccine

The bear market has been brutal. Given the trend in inflation and weakening economy, it's unlikely to end soon. For investors, the best strategy is to use the adverse market conditions to scoop up stocks that have a long-term history of compounding earnings. Therefore, investors should consider buying Builders FirstSource…

The Therapeutic Goods Administration approves Pfizer's paediatric dose of its COVID vaccine for children aged between six months and five years old.

The Therapeutic Goods Administration has given provisional approval for Pfizer's COVID-19 booster to be used in children aged six months to five years.

As biotech leaders Vertex and Crispr shoot for a gene-editing first, VRTX stock takes aim at a new breakout.